Is a lower carcinoembryonic antigen (CEA) level always better?
Jan 07, 2022
Source: Cainiu Health
Dr. Zhu Zengkuan
Introduction
The lower the carcinoembryonic antigen (CEA) level, the better. On hospital laboratory reports, the upper limit of the normal CEA reference range is typically 5 ng/mL; thus, a value below 5 ng/mL is considered within the normal range. Therefore, a CEA level below 5 ng/mL indicates a normal CEA level for the patient.
Cancer diagnosis is a highly complex process. When patients exhibit symptoms suggestive of malignant tumors, multiple diagnostic tests must be performed before a definitive diagnosis can be established. One such test is tumor marker testing, which yields a quantitative value that serves as a valuable reference for tumor assessment. Generally, elevated carcinoembryonic antigen (CEA) levels strongly suggest the presence of malignancy. But does this mean “the lower the CEA level, the better”? Below, we address this question.
Is a Lower CEA Level Always Better?
Yes—lower CEA levels are generally preferable. On standard hospital laboratory reports, the upper limit of the normal CEA reference range is typically 5 ng/mL; values below 5 ng/mL are considered within the normal range. Thus, a CEA level below 5 ng/mL indicates a normal baseline.
In many malignant tumors—including gastric cancer, colorectal cancer, breast cancer, and pancreatic cancer—CEA levels may rise to more than five times the upper limit of normal. For instance, CEA concentrations may reach 50 ng/mL or even higher, warranting strong clinical suspicion of underlying malignancy.
Knowledge Extension: What Does the CEA Test Assess?
First, CEA testing aids in the screening of malignant tumors and enables early detection of cancers such as colorectal cancer, gastric cancer, pancreatic cancer, medullary thyroid carcinoma, and breast cancer. In these conditions, serum CEA levels often increase abnormally—sometimes markedly exceeding the normal reference range—prompting clinicians to take immediate notice. Patients with elevated CEA should undergo further evaluation in conjunction with clinical symptoms to avoid diagnostic delay.
Second, CEA levels may also rise—albeit to varying degrees—in certain inflammatory or benign conditions, including diabetes, colitis, hepatitis, cardiovascular disease, and pancreatitis.
The above addresses the question: “Is a lower CEA level always better?” We hope this information proves helpful.
